Eledon Pharmaceuticals (NasdaqCM:ELDN) FY Conference November 12, 2025 10:30 AM ET Speaker0Ready to get started. All right, thanks everyone for joining us here, on the second annual Guggenheim Healthcare Innovation Conference. I'm Val de Devond, one of the biopharma analysts here at Guggenheim. Joining us in this room next, we have the Eledon Pharmaceuticals team. We did have one victim to some of the travel issues, who was not able to join us, and that's the CEO, David-Alexandre Gros. But we do have Steve ...

Phase 2 BESTOW Clinical Trial Results November 7, 2025 Forward -Looking Statements This presentation contains forward ‐looking statements that involves substantial risks and uncertainties. Any statements about the company's future expectations, plans and prospects, including statements about its strategy, future operations, development of its product candidates, and other statements containing the words "believes," "anticipates," "plans," "expects," "estimates," "intends," "predicts," "projects," "targets," ...